Ignite Creation Date:
2025-12-24 @ 6:40 PM
Ignite Modification Date:
2026-02-24 @ 7:58 PM
Study NCT ID:
NCT02237157
Status:
COMPLETED
Last Update Posted:
2021-05-07
First Post:
2014-09-08
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Dose Escalation Safety Study of Locally-Delivered Gemcitabine in Pancreatic Cancer
Sponsor:
RenovoRx
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Pancreatic Cancer | View |